Metformin and Temsirolimus: Metastatic or Unresectable Solid Tumor (Ontario CA)
http://clinicaltrials.gov/ct2/show/N...+cancer&rank=2
Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma http://clinicaltrials.gov/ct2/html/i...e/triangle.gif Purpose RATIONALE: Metformin and temsirolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.This study is currently recruiting participants. Verified by National Cancer Institute (NCI), April 2008 First Received: April 15, 2008 Last Updated: October 8, 2008 History of Changes Sponsored by: London Regional Cancer Program at London Health Sciences Centre Information provided by: National Cancer Institute (NCI) ClinicalTrials.gov Identifier: NCT00659568 PURPOSE: This phase I trial is studying the side effects and best dose of metformin when given together with temsirolimus in treating patients with metastatic or unresectable solid tumor or lymphoma. Condition Intervention Phase Breast Cancer Endometrial Cancer Kidney Cancer Lung Cancer Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Drug: metformin hydrochloride Drug: temsirolimus Phase 1 Other Metformin studies: http://clinicaltrials.gov/ct2/result...tformin+cancer |
All times are GMT -7. The time now is 10:08 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021